Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009–2014

Approximately 1% of the population suffers from rheumatoid arthritis (RA) worldwide (0.45% in Poland). The therapy consists of the use of disease-modifying antirheumatic drugs (DMARDs). Biologics are used in the form of the drug programme. Analysis of the NHF database demonstrated the sequence of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tłustochowicz, Małgorzata, Śliwczyński, Andrzej M, Brzozowska, Melania, Teter, Zbigniew, Marczak, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949902/
https://www.ncbi.nlm.nih.gov/pubmed/29765444
http://dx.doi.org/10.5114/aoms.2016.58924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949902/
https://www.ncbi.nlm.nih.gov/pubmed/29765444
http://dx.doi.org/10.5114/aoms.2016.58924

Ejemplares similares